Patent · US Active

Therapeutic inhibition of lactate dehydrogenase and agents therefor

US10738311B2 · kind B2 · utility

3Cited by

3References

39Claims

0Family size

Assignee

Dicerna Pharmaceuticals, Inc. · US

Inventors

Bob D. Brown · Littleton, US
Henryk T. Dudek · Wellesley, US
Cheng-Yu Lai · Daxi District, TW

Key dates

Filing date	Mar 15, 2019
Grant date	Aug 11, 2020
Priority date	—
Expiry date	Mar 15, 2039

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention relates to compounds, compositions, and methods useful for reducing lactact dehydrogenase target RNA and protein levels via use of ds RNAs, e.g., Dicer substrate siRNA (DsiRNA) agents.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.